Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Peptides

Exenatide Acetate 141732-76-5

Exenatide Acetate 141732-76-5

Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.

Product Name: Exenatide acetate
Synonyms: EXENATIDE ACETATE;ENFUVIRTIDE ACETATE;Exenatide;His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH{2};EXENATIDE ACETATE(EXENDIN-4);Extendin-4;Unii-9p1872D4ol;His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
CAS: 141732-76-5
MF: C186H284N50O62S
MW: 4244.60796

GMP for Exenatide Acetate 141732-76-5 is available.
 
Disclaimer:Those products (Exenatide Acetate 141732-76-5) patented are for lab analytical & research purposes only.